70 likes | 82 Views
Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world, which in turn increases the geriatric population. This drives the need of anticoagulant products among the population. Additionally, rise in adoption of Novel Oral Anticoagulants (NOACs) boosts the growth of the global anticoagulant market.
E N D
Anticoagulants Market Anticoagulants Market Segmentation by Route of Administration - Oral, Injectables; Drug Class - Factor XA Inhibitors, Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists; Indication - Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation and Heart Attack; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Forecast 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved
Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Anticoagulants Market Chapter 4 Market Overview Chapter 5 Global Anticoagulants Market Analysis and Forecast, by Route of Administration Chapter 6 Global Anticoagulants Market Analysis and Forecast, by Drug Class Chapter 7 Global Anticoagulants Market Analysis and Forecast, by Indication Chapter 8 Global Anticoagulants Market Analysis and Forecast, by Distribution Channel Chapter 9 Global Anticoagulants Market Analysis and Forecast, by Region Chapter 10 North America Anticoagulants Market Analysis and Forecast Chapter 11 Europe Anticoagulants Market Analysis and Forecast Chapter 12 Asia Pacific Anticoagulants Market Analysis and Forecast Chapter 13 Latin America Anticoagulants Market Analysis and Forecast Chapter 14 Middle East & Africa Anticoagulants Market Analysis and Forecast Chapter 15 Competitive Landscape ©2019 Transparency Market Research, All Rights Reserved
Anticoagulants Market - Snapshot lAnticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. lHeparins, including unfractionated heparin (UFH) and low molecular weight heparin; vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. lAccording to the report, the global anticoagulants market is projected to expand at a CAGR of 8.0% from 2018 to 2026. ©2019 Transparency Market Research, All Rights Reserved
Reports Highlights •Rise in prevalence of obesity, increase in hip and knee surgeries, and surge in cases of coagulation disorders are anticipated to boost the Anticoagulants market from 2018 to 2026. growth of the global •Dwindling birth rates have led to an increase in the geriatric population. •Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world. Request For Sample ©2019 Transparency Market Research, All Rights Reserved
Continue.. lThe rise in adoption of Novel Oral Anticoagulants (NOACs) boosts market growth. NOACs target either factor Xa to avoid or to treat thrombosis. lAccording to CDC 2016 report, over a million people in the U.S. undergo hip and knee replacement surgeries. lKey players operating in the global anticoagulants market include Bayer Healthcare, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company. Request For Brochure ©2019 Transparency Market Research, All Rights Reserved
Contact To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You ©2019 Transparency Market Research, All Rights Reserved